- Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study (Diabetes Metab J 2022;46: 658-62)
-
Kawada T
- KMID: 2531970
- Diabetes Metab J.
- 2022 Jul;46(4):663-664.
- doi: 10.4093/dmj.2022.0131
-
- CITED
-
- Close
- SHARE
-
- Close
- Beyond Liver Disease: Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Kidney Disease
-
Han E
- KMID: 2531960
- Diabetes Metab J.
- 2022 Jul;46(4):564-566.
- doi: 10.4093/dmj.2022.0203
-
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study (Diabetes Metab J 2022;46: 658-62)
-
Kim HS, Lee WJ
- KMID: 2531971
- Diabetes Metab J.
- 2022 Jul;46(4):665-666.
- doi: 10.4093/dmj.2022.0166
-
- CITED
-
- Close
- SHARE
-
- Close
- Prevalence of Diabetic Retinopathy in Undiagnosed Diabetic Patients: A Nationwide Population-Based Study
-
Jang HN, Moon MK, Koo BK
- KMID: 2531965
- Diabetes Metab J.
- 2022 Jul;46(4):620-629.
- doi: 10.4093/dmj.2021.0099
Background: We investigated the prevalence of diabetic retinopathy (DR) in patients with undiagnosed diabetes through a nationwide survey, compared to those with known diabetes. Methods: Among the participants of the Korean... -
- CITED
-
- Close
- SHARE
-
- Close
- Endoplasmic Reticulum Stress and Dysregulated Autophagy in Human Pancreatic Beta Cells
-
Moon S, Jung HS
- KMID: 2531957
- Diabetes Metab J.
- 2022 Jul;46(4):533-542.
- doi: 10.4093/dmj.2022.0070
Pancreatic beta cell homeostasis is crucial for the synthesis and secretion of insulin; disruption of homeostasis causes diabetes, and is a treatment target. Adaptation to endoplasmic reticulum (ER) stress through... -
- CITED
-
- Close
- SHARE
-
- Close
- Current Trends of Big Data Research Using the Korean National Health Information Database
-
Kim MK, Han K, Lee SH
- KMID: 2531959
- Diabetes Metab J.
- 2022 Jul;46(4):552-563.
- doi: 10.4093/dmj.2022.0193
Recently, medical research using big data has become very popular, and its value has become increasingly recognized. The Korean National Health Information Database (NHID) is representative of big data that... -
- CITED
-
- Close
- SHARE
-
- Close
- Renoprotective Mechanism of Sodium-Glucose Cotransporter 2 Inhibitors: Focusing on Renal Hemodynamics
-
Kim NH, Kim NH
- KMID: 2531958
- Diabetes Metab J.
- 2022 Jul;46(4):543-551.
- doi: 10.4093/dmj.2022.0209
Diabetic kidney disease (DKD) is a prevalent renal complication of diabetes mellitus that ultimately develops into end-stage kidney disease (ESKD) when not managed appropriately. Substantial risk of ESKD remains even... -
- CITED
-
- Close
- SHARE
-
- Close
- Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
-
Seo DH, Suh YJ, Cho Y, Ahn SH, Seo S, Hong S, Lee Yh, Choi YJ, Lee E, Kim SH
- KMID: 2531966
- Diabetes Metab J.
- 2022 Jul;46(4):630-639.
- doi: 10.4093/dmj.2021.0130
Background: Nonalcoholic fatty liver disease (NAFLD) is associated with chronic kidney disease (CKD). However, the causal relationship between NAFLD and CKD is uncertain, particularly in patients with type 2 diabetes... -
- CITED
-
- Close
- SHARE
-
- Close
- Development of Various Diabetes Prediction Models Using Machine Learning Techniques
-
Shin J, Kim J, Lee C, Yoon JY, Kim S, Song S, Kim HS
- KMID: 2531968
- Diabetes Metab J.
- 2022 Jul;46(4):650-657.
- doi: 10.4093/dmj.2021.0115
Background: There are many models for predicting diabetes mellitus (DM), but their clinical implication remains vague. Therefore, we aimed to create various DM prediction models using easily accessible health screening... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study
-
Kim HS, Yoon T, Jung CH, Park JY, Lee WJ
- KMID: 2531969
- Diabetes Metab J.
- 2022 Jul;46(4):658-662.
- doi: 10.4093/dmj.2021.0232
Sodium-glucose cotransporter 2 inhibitor (SGLT2i) and glucagon-like peptide-1 receptor agonist (GLP-1RA) are novel anti-diabetic drugs whose glucose-lowering effect and cardiovascular and renal benefits were evidenced in clinical trials. We investigated... -
- CITED
-
- Close
- SHARE
-
- Close
- Fatty Acid-Binding Protein 4 in Patients with and without Diabetic Retinopathy
-
Huang P, Zhao X, Sun Y, Wang X, Ouyang R, Jiang Y, Zhang X, Hu R, Tang Z, Gu Y
- KMID: 2531967
- Diabetes Metab J.
- 2022 Jul;46(4):640-649.
- doi: 10.4093/dmj.2021.0195
Background: Fatty acid-binding protein 4 (FABP4) has been demonstrated to be a predictor of early diabetic nephropathy. However, little is known about the relationship between FABP4 and diabetic retinopathy (DR).... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Different Types of Diagnostic Criteria for Gestational Diabetes Mellitus on Adverse Neonatal Outcomes: A Systematic Review, Meta-Analysis, and Meta-Regression
-
Tehrani FR, Naz MSG, Bidhendi-Yarandi R, Behboudi-Gandevani S
- KMID: 2531964
- Diabetes Metab J.
- 2022 Jul;46(4):605-619.
- doi: 10.4093/dmj.2021.0178
Background: Evidence supporting various diagnostic criteria for diagnose gestational diabetes mellitus (GDM) are consensus-based, needs for additional evidence related to outcomes. Therefore, the aim of this systematic-review and meta-analysis was... -
- CITED
-
- Close
- SHARE
-
- Close
- Reproductive Life Span and Severe Hypoglycemia Risk in Postmenopausal Women with Type 2 Diabetes Mellitus
-
Kang S, Park YM, Kwon DJ, Chung YJ, Namkung J, Han K, Ko SH
- KMID: 2531962
- Diabetes Metab J.
- 2022 Jul;46(4):578-591.
- doi: 10.4093/dmj.2021.0135
Background: Estrogen promotes glucose homeostasis, enhances insulin sensitivity, and maintains counterregulatory responses in recurrent hypoglycemia in women of reproductive age. Postmenopausal women with type 2 diabetes mellitus (T2DM) might be... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparative Effects of Sodium-Glucose Cotransporter 2 Inhibitor and Thiazolidinedione Treatment on Risk of Stroke among Patients with Type 2 Diabetes Mellitus
-
Lee SE, Nam H, Choi HS, Kim H, Kyoung DS, Kim KA
- KMID: 2531961
- Diabetes Metab J.
- 2022 Jul;46(4):567-577.
- doi: 10.4093/dmj.2021.0160
Background: Although cardiovascular outcome trials using sodium-glucose cotransporter-2 inhibitors (SGLT-2i) showed a reduction in risk of 3-point major adverse cardiovascular events (MACE), they did not demonstrate beneficial effects on stroke... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Low-Dose Persistent Organic Pollutants on Mitochondrial Function: Human and in Vitro Evidence
-
Kim SA, Lee H, Park SM, Kim MJ, Lee YM, Yoon YR, Lee HK, Moon HB, Lee IK, Lee DH
- KMID: 2531963
- Diabetes Metab J.
- 2022 Jul;46(4):592-604.
- doi: 10.4093/dmj.2021.0132
Background: Chronic exposure to low-dose persistent organic pollutants (POPs) can induce mitochondrial dysfunction. This study evaluated the association between serum POP concentrations and oxygen consumption rate (OCR) as a marker... -
- CITED
-
- Close
- SHARE
-
- Close
- New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
-
Kim K, Ginsberg HN, Choi SH
- KMID: 2531956
- Diabetes Metab J.
- 2022 Jul;46(4):517-532.
- doi: 10.4093/dmj.2022.0198
Statins are the cornerstone of the prevention and treatment of atherosclerotic cardiovascular disease (ASCVD). However, even under optimal statin therapy, a significant residual ASCVD risk remains. Therefore, there has been... -
- CITED
-
- Close
- SHARE
-
- Close
